Tada/GAC,

Here's a post from a few weeks ago on the updated BETonMACE ClinicalTrials.gov page. This science geek didn't see anything then that was significant. A few small changes noted in my previous message. However, the time in the trial hasn't changed. A slight change to the title of the study to remove "up to 104 weeks dosing", though the 120 week trial timeframe that existed in the previous version remains unchanged. In other words, they did not replace 104 weeks with 120 weeks anywhere in the protocol. You can look up archived versions of the older protocols too and compare them (see my previous link). 

Tada, I also didn't see anything explicitly mentioning an Alzheimer's or a Montreal Cognitive Test. The only thing I see in the ClinicalTrials.gov protocol is "Health Related Quality of Life (HRQOL) as measured using the EQ-5D-5L [ Time Frame: 122 weeks ]." But I'm not entirely sure that this is related to Alzheimer's/Cognitive testing.

BearDownAZ